The Community Liver Alliance is collaborating with the University of Pittsburgh Medical Center: Liver Research Center and the Allegheny Health Network: Cancer Center to host the 4th Annual Liver Cancer Conference.
Our speakers represent experts from the state and across the nation to bring up to date information in a one-day program with general sessions and case presentations.
This virtual conference will be held on Saturday, October 29, 2022 9:45 am – 3:00 pm EST.
Register here: https://cvent.me/gebqeo
Attendee Hub: https://cvent.me/gnVO5B
Program Overview
The goal of this course module is to help clinicians and other service providers understand the management of Hepatocellular Carcinoma in the US population, innovations in therapies and advances in research and development.
Learning Objectives
At course completion, attendees should be able to:
-Increase Knowledge
Understand the molecular classification of HCC
Understand the multidisciplinary approach to management of HCC
-Competency
Define the mechanisms that lead to the development of hepatocellular cancer (HCC)
-Performance
Discuss the available evidence-based data on promising treatment options for advanced HCC
Discuss the advances in research and development
Course Directors
Dulabh K. Monga, MD
Program Director
Hematology Oncology Fellowship
Assistant Professor of Medicine
Temple University School of Medicine
Allegheny Health Network
Pittsburgh, PA
Satdarshan (Paul) Singh Monga, MD
UPMC Endowed Chair for Experimental Pathology
Professor of Pathology and Medicine
Director, Pittsburgh Liver Research Center,
Chief and Vice Chair, Division of Experimental Pathology
University of Pittsburgh, School of Medicine and UPMC
Pittsburgh, PA
Schedule
9:45 a.m. – 10:00 a.m.
Welcome and Overview
Dulabh K Monga, MD and Satdarshan (Paul) Monga, MD
Course Directors
Suzanna Masartis
CEO, Community Liver Alliance
10:00 a.m. – 10:30 a.m.
How Does Liver Cancer Develop?
Satdarshan (Paul) Monga, MD
Professor and Vice Chair of Pathology
Director, Pittsburgh Liver Research Center
University of Pittsburgh and UPMC
Pittsburgh, PA
10:30 a.m. – 11:00 a.m.
HCC Surveillance in High Risk Liver Cancer
Renumathy Dhanasekaran, MD
Assistant Professor, Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Stanford, CA
11:00 a.m. – 11:30 a.m.
Role of Surgical Resection and Transplantation in HCC Management
Rachel Tindall, MD, FACS
Transplant Surgeon, Hepatobiliary & Pancreas Cancer
Allegheny Health Network
Pittsburgh, PA
11:30 a.m. -12:00 p.m.
Role of Locoregional Therapies in HCC Management
Riad Salem, MD
Vice-Chair, Image-Guided Therapy
Chief, Interventional Radiology and Oncology
Department of Radiology
Feinberg School of Medicine
Northwestern University
Chicago, IL
12:00 p.m. – 12:30 p.m.
BREAK/Exhibits
12:30 p.m. – 1:00 p.m.
Medical Management of HCC
Dulabh K Monga, MD
Associate Professor of Medicine
Drexel University School of Medicine
Allegheny Health Network Cancer Institute
Pittsburgh, PA
1:00 p.m. 1:30 p.m.
Radiation Therapy for HCC
Paul Renz, DO
Radiation Oncology Specialist
Allegheny Health Network Cancer Institute
Pittsburgh, PA
1:30 p.m. – 2:00 p.m.
Molecular Pathology of Hepatobiliary Tumors
Aatur Singhi, MD, PhD
Assistant Professor of Pathology
University of Pittsburgh and UPMC
Pittsburgh, PA
2:00 p.m. – 2:30 p.m.
Advances in the Management of Biliary Tract Cancers
Rachna Shroff, MD, MS
Associate Professor of Medicine
Chief, GI Medical Oncology
University of Arizona Cancer Center
Tucson, AZ
2:30 p.m. – 3:00 p.m.
Palliative Care of Cancer Patients
Sidra Anwar, MD
Hospice & Palliative Medicine Specialist
Allegheny Health Network
Pittsburgh, PA
3:00 p.m.
Case Presentations/Q & A
Resectable/Transplantable HCC
Non-Resectable Non-Transplantable HCC and
Medical and Locoregional Options
Intrahepatic Cholangiocarcinoma
Paul Renz, DO
Dulabh Monga, MD
Riad Salem, MD
Rachna Shroff, MD
Rachel Tindall, MD
Register here: https://cvent.me/gebqeo
Attendee Hub: https://cvent.me/gnVO5B